Zobrazeno 1 - 10 of 128 pro vyhledávání: '"E, Baltali"'
1
Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy
Autor: L. Ottestad, Per Eystein Lønning, J.G.M. Klijn, W. Mietlowski, M. Csepreghy, J.P. Guastalla, E. Baltali, H. Sommer, S.I. Helle, I. Szakolczai, C. Boni, T. Pinter, C. Bryce, Emilio Bajetta
Publikováno v: European Journal of Cancer, 41(5), 694-701. Elsevier Ltd.
The insulin-like growth factor (IGF)-system was evaluated in 150 breast cancer patients participating in a randomised phase III trial comparing octreotide pamoate and tamoxifen with tamoxifen+placebo. Alterations in the IGF-system in the two treatmen
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fc9e298236bb3329ec11f6ff3f649c1
https://doi.org/10.1016/j.ejca.2004.12.015
Zobrazit plný text záznamu
2
CA 15-3, Ceruloplasmin and tissue polypeptide specific antigen as a tumour marker panel in breast cancer
Autor: Ozgur Ozyilkan, E Baltali, Serafettin Kirazli
Publikováno v: Ozgur Ozyilkan
East African Medical Journal; Vol 77, No 6 (2000)
Scopus-Elsevier
Tumour markers along with other tests, may be useful in the assessment of the prognosis, monitoring response to treatment and early detection of metastases in breast cancer. The most commonly used breast cancer antigen is CA 15-3.To examine the value
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02bfd9afd127a18d9e76487afb5c7421
https://doi.org/10.4314/eamj.v77i6.46635
Zobrazit plný text záznamu
3
Reproductive tract pathology in asymptomatic women treated with tamoxifen
Autor: K, Yüce, Z S, Tuncer, C, Oncüloğlu, A, Ayhan, E, Baltali, N, Güier
Publikováno v: European journal of gynaecological oncology. 22(6)
To determine the long-term effects of tamoxifen on the female reproductive tract in patients with breast cancer.Forty-nine patients with breast cancer receiving tamoxifen longer than two years were analyzed. All the patients underwent pelvic examinat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::72caec282164ebf00daf954165ae6b97
https://pubmed.ncbi.nlm.nih.gov/11874085
Zobrazit plný text záznamu
4
Neoadjuvant chemotherapy in locally advanced breast cancer: a preliminary report. Turkish Oncology Study Group
Autor: E, Baltali, N, Günel, D A, Onat, I L, Atahan, Z, Akçali, E, Büyükünal, D, Firat
Publikováno v: Tumori. 85(6)
A pilot study of neoadjuvant chemotherapy with cyclophosphamide-epirubicin-5-fluorouracil (FEC) was performed on 85 patients with locally advanced breast cancer.Patients received four cycles of neoadjuvant chemotherapy followed by surgery, radiothera
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2e2917569bd00d9897613321f5e9db2e
https://pubmed.ncbi.nlm.nih.gov/10774570
Zobrazit plný text záznamu
5
Bolus and continuous infusion mitoxantrone in newly diagnosed adult acute lymphoblastic leukemia: results of two consecutive phase II clinical studies
Autor: Y, Koc, G, Akpek, E, Kansu, A, Kars, G, Tekuzman, E, Baltali, N, Güler, I, Barista, I, Güllü, Y, Ozisik, D, Firat
Publikováno v: Cancer investigation. 16(6)
Two consecutive phase II clinical studies were designed to evaluate the efficacy and safety of bolus and continuous infusion (CI) mitoxantrone (MTZ) in 39 patients with newly diagnosed acute lymphocytic leukemia (ALL). MTZ was used as part of the cla
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e2d80160c1120f9b8d4a429eae340024
https://pubmed.ncbi.nlm.nih.gov/9679525
Zobrazit plný text záznamu
6
The impact of diagnosis and treatment on the quality of life in breast cancer patients
Autor: O, Ozyilkan, E, Baltali, G, Tekuzman, D, Firat
Publikováno v: Neoplasma. 45(1)
Over the past years, quality of life (QOL) in patients with breast cancer has continued to be a noteworthy area of research. The diagnosis and management of cancer can have a major impact on every aspect of a patient's QOL. Sixteen women with breast
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0b116d455d1ab48d798eb44cd16b0d7b
https://pubmed.ncbi.nlm.nih.gov/9605003
Zobrazit plný text záznamu
8
Procarbazine, CCNU, vincristine combination in the treatment of brain tumors
Autor: I H, Güllü, I, Celik, G, Tekuzman, M, Altunbaş, N, Güler, I, Barişta, N, Alkiş, S, Yalçin, A, Kars, E, Baltali, E, Kansu, D, Firat
Publikováno v: Tumori. 82(3)
Forty patients with primary malignant brain tumor were treated by combination chemotherapy after prior treatment with surgery and radiotherapy. The chemotherapy schedule consisted of PCV: procarbazine per os, 100 mg/m2, during 14 consecutive days; CC
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7dc40633cf8cc7350d36743231c7b209
https://pubmed.ncbi.nlm.nih.gov/8693599
Zobrazit plný text záznamu
9
Solitary phalanx plasmacytoma relapse with disseminated extramedullary plasmacytomas and myeloma after short duration of remission
Autor: I, Celik, E, Baltali, I, Barişta, G, Tekuzman, E, Kansu, L, Atahan, Y, Güngen, D, Firat
Publikováno v: Anticancer research. 16(2)
Solitary bone plasmacytomas account for 5-7% of multiple myeloma cases and are assumed to have a fairly good prognosis, with a long duration of relapse-free survival after primary local treatment. Isolated phalanx plasmacytoma is a very rare entity,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::da714c4c35dabfdceda79c352919cf8c
https://pubmed.ncbi.nlm.nih.gov/8687159
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje